Compound ID | 241

Update compound information

TP-076

Synonym(s): TP-6076

Class: Tetracycline

Spectrum of activity: Gram-negative
Details of activity: Carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Acinetobacter; Pathogens targeted include carbapenem-resistant variants of Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coli and Pseudomonas aeruginosa.
Propensity to select resistant mutants: Yes
Description: In Vivo Efficacy of Novel, Fully Synthetic Tetracyclines in a Murine Lung Infection Model Challenged with KPC-producing Klebsiella pneumoniae T. Grossman, C. Fyfe, K. Kerstein, C. Sun, D. Hunt, R. Clark, X. Xiao, J. Sutcliffe
Institute where first reported: Tetraphase Pharmaceuticals, USA
Year first mentioned: 2014
Highest developmental phase: Phase 1
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 579.57
Iso. SMILES: CCN(CC)[C@H]1[C@@H]2C[C@@H]3CC4=C(C(=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)[C@@H]5CCCN5)C(F)(F)F
InChI Key: SRAXMTXWTUABCM-DOYYSQEVSA-N
Can. SMILES: CCN(CC)[C@H]1[C@@H]2C[C@@H]3CC4=C(C(=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)[C@@H]5CCCN5)C(F)(F)F
InChI: InChI=1S/C28H32F3N3O7/c1-3-34(4-2)21-14-9-11-8-13-18(16(35)10-12(15-6-5-7-33-15)20(13)28(29,30)31)22(36)17(11)24(38)27(14,41)25(39)19(23(21)37)26(32)40/h10-11,14-15,21,33,35-36,39,41H,3-9H2,1-2H3,(H2,32,40)/t11-,14-,15-,21-,27-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/162423126
Guide to Pharmacology: TP-6076
Citations:
  • https://www.ncbi.nlm.nih.gov/pubmed/28654780
  • https://www.ncbi.nlm.nih.gov/pubmed/29559273
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805024/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.